Inspector Jacques Clouseau, famously unable to crack the simplest of murder cases, would most certainly be confounded by the case we face. While Inspector Clouseau searched for the answer to the question, “Who did it?”, we must search for the answer to the question, “Who owns it?” In 1962, Maurice Richlin coauthored a story treatment (the “Treatment”) 1 involving the bumbling inspector. Later that year, before publication, 2 Richlin assigned all rights in the Treatment—including copyright and the right to renew that copyright—to a corporation that used it to create the smash-hit film, The Pink Panther (the “Motion Picture”). The Richlin heirs now claim federal statutory renewal rights in the Treatment and derivative works, including the Motion Picture. They assert that Richlin’s coauthorship of the Treatment makes him a coauthor of the Motion Picture. Alternatively, they contend that, because the Motion Picture secured statutory protection for the portions of the Treatment incorporated into the Motion Picture, and because the eopy-right in the Motion Picture was renewed for a second term, they are co-owners of the Motion Picture’s renewal copyright and all derivative works thereof. Although the Richlin heirs have developed several theories that could supply the answer to the question, “Who owns it?”, unlike Inspector Clouseau, they have not quite stumbled upon a theory that favors them. We therefore affirm the district court’s conclusion that the Richlin heirs have no interest in the copyright to the Motion Picture.
I. BACKGROUND
The material facts are largely undisputed. In April 1962, Maurice Richlin and Blake Edwards coauthored a fourteen-page Treatment initially entitled
The Pink Rajah,
but later renamed
The Pink Panther.
The Treatment served as the basis for the well-known motion picture,
The Pink Panther,
and numerous derivative works. It appears that the Treatment set forth many of the plot elements and characters, including Inspector Clouseau him
Richlin and Edwards entered into an employment agreement dated May 14, 1962 (the “Employment Agreement”) with the Mirisch Corporation of Delaware (“Mirisch”) to write the screenplay for the Motion Picture. 3 They agreed to create the screenplay as a “work made for hire.” Under this contract, Richlin and Edwards combined received $150,000 for their work on the Treatment and the screenplay. 4
Later that month, on May 24, 1962, Richlin and Edwards executed a literary assignment agreement (the “Assignment”) whereby they transferred and assigned “forever ... that certain story (which term shall cover all literary material written by [Richlin and Edwards] in connection therewith including any adaptations, treatments, scenarios, dialogue, scripts and/or screenplays) entitled: ‘Pink Rajah’ also entitled or known as ‘Pink Panther’ ” in exchange for $1 “and other good and valuable consideration in hand” paid by Mirisch. Mirisch also received “the right to use [Richlin’s and Edwards’s] name[s] as the author of the literary composition upon which said adaptations, or any of them, are based.” The Assignment further provided that if Mirisch copyrighted the Treatment, Mirisch “shall enjoy its rights hereunder for the full duration of such copyright or copyrights, including any and all renewals thereof.” 5
In 1963, The Pink Panther was released and distributed in theaters to great acclaim. It was followed by nine movie sequels, 6 many of which gave screen credit to Richlin and Edwards for creating the characters. The original Motion Picture bears a copyright notice of 1963 in the name of Mirisch and G & E Productions. In 1964, the U.S. Copyright Office issued a certificate of registration for the “motion picture” entitled “The Pink Panther” under the Copyright Act of 1909 (“1909 Act”).
The Certificate of Registration identifies the claimant and author as “Mirisch-G & E Productions.” The certificate lists the date of publication as March 18, 1964, but notes that the copyright notice on the Motion Picture bears a date of 1963. The Richlin heirs concede that neither the Treatment nor the screenplay was ever separately published or registered for federal copyright protection.
Richlin died on November 13, 1990. The original term of copyright in the Mo
The Richlin heirs filed suit in the United States District Court for the Central District of California seeking declaratory relief and an accounting. They claim a 50 percent renewal interest in the Treatment and all derivative works. During the course of this litigation, the theories un-dergirding this claim have evolved. The complaint relies on the theory that publication of the derivative work (the Motion Picture) effectuated publication of the underlying work (the Treatment). Under this theory, when MGM renewed the Motion Picture’s statutory copyright in 1991, this renewed the copyright in the Treatment on behalf of the Richlin heirs, which gave the Richlin heirs an interest in the Motion Picture’s renewal copyright. These principles carry some theoretical weight in copyright law; however, the Richlin heirs failed to renew their statutory copyright, if any, in the Treatment in 1991. That may explain why, by the time the district court granted summary judgment in favor of MGM, the Richlin heirs had abandoned their argument based on a statutory copyright in the Treatment. Instead, they argued that they have a copyright interest in the Motion Picture as coauthors based on Richlin’s coauthorship of the Treatment, which was incorporated into the Motion Picture. The district court analyzed the requirements of a “joint work” prepared by coauthors, who under copyright law would each be deemed an owner of the copyright. The court rejected this theory because, under the factors set forth in
Aalmuhammed v. Lee,
II. JURISDICTION AND STANDARD OF REVIEW
The district court had jurisdiction pursuant to 28 U.S.C. § 1338, which confers subject matter jurisdiction over copyright actions. We have jurisdiction over final judgments of the district courts pursuant to 28 U.S.C. § 1291.
We review a district court’s grant of summary judgment de novo.
Bagdadi v. Nazar,
III. DISCUSSION
On appeal, the Richlin heirs maintain their contention that because Richlin and Edwards jointly authored the Treatment, and the Treatment became a critical component of the Motion Picture, Richlin was a coauthor of the Motion Picture, and was therefore a co-owner on whose heirs’ behalf MGM secured a renewal interest in the Motion Picture’s copyright in 1991. Alternatively, the Richlin heirs resort to the theory underlying their complaint. They contend that publication of the Treatment with the Motion Picture secured a statutory copyright for the Treatment, which was renewed on their behalf by MGM when it renewed the Motion Picture’s copyright. We address each argument in turn.
A. Coauthorship of the Motion Picture
To determine whether Richlin had an interest in the Motion Picture’s federal statutory copyright, we must consider the question of coauthorship. The Richlin heirs argue that because Richlin coauthored the Treatment, which was a substantial component of the Motion Picture, he is also a coauthor of the Motion Picture. This coauthorship, according to the Richlin heirs, gives them an interest in the Motion Picture’s copyright. Under this facially appealing, but legally unsustainable, argument, an interest in the renewal term of copyright and all subsequent motion pictures and adaptations based on that copyright would revert to the Richlin heirs. 8 See 17 U.S.C. § 201(a) (1976) (“The authors of a joint work are co-owners of copyright in the work.”).
We agree with the district court that Richlin and Edwards were not coauthors of the Motion Picture. Richlin and Edwards wrote the Treatment in 1962, and the Motion Picture was copyrighted when published with notice in 1963; therefore, the Richlin heirs’ claim of coauthorship is governed by the 1909 Act. The 1909 Act, however, did not expressly mention or define joint works or coauthorship. Nevertheless, as early as 1915, in
Maurel v. Smith,
Judge Learned Hand applied the universally adopted common law definition of joint authors to the 1909 Act, holding that they “undertake jointly to write a play, agreeing on the general outline and design and sharing the labor of working it out.”
Section 101 of the 1976 Act defines “joint work” as “a work prepared by two or more authors with the intention that their contributions be merged into inseparable or interdependent parts of a unitary whole.” 17 U.S.C. § 101 (1976). A “joint work” requires each author to make “an independently copyrightable contribution.”
Ashton-Tate Corp. v. Ross,
In
Aalmuhammed v. Lee,
The plain language of § 101 makes clear that Richlin is a coauthor of the Treatment. Viewing the facts in the light most favorable to the Richlin heirs, Richlin and Edwards could have secured statutory copyright for the Treatment before assigning it to Mirisch, as it was a fourteen-page original creative story written jointly by Richlin and Edwards. See 17 U.S.C. § 4 (1909) (“The works for which copyright may be secured under this title shall include all the writings of an author.”); 17 U.S.C. § 102 (1976) (“Copyright protection subsists ... in original works of authorship fixed in any tangible medium of expression----”); 1 Nimmer §§ 2.04 and 6.01 (articulating standards for “literary works” and “joint works”). Moreover, the Treatment “was prepared by two or more authors,” Richlin and Edwards, who clearly intended that it be “merged into inseparable or interdependent parts of a unitary whole.” 17 U.S.C. § 101 (1976). Indeed, this is what Richlin and Edwards accomplished when they presented the completed Treatment to Mirisch.
But the Treatment is not the appropriate reference point. The Richlin heirs’ claim for declaratory relief and an accounting rests on their argument that, by virtue of his contribution to the Treatment, Rich-lin is coauthor of the Motion Picture. Thus, the work that must be examined to determine joint authorship is the Motion Picture, not the Treatment. The plain
We must first determine whether “putative coauthors ma[de] objective manifestations of a shared intent to be coauthors.”
Aalmuhammed,
In light of the Assignment, the Employment Agreement, and the surrounding circumstances, there were no “objective manifestations of a shared intent to be coauthors.”
Aalmuhammed,
The second factor—whether Rich-lin supervised the Motion Picture by exercising control'—favors MGM as well. Riehlin did not exercise any supervisory powers over the Motion Picture, a factor that
Aalmuhammed
indicates will often be the most important.
Aalmuhammed,
We agree with the district court that the third factor, whether “the audience appeal of the work” can be attributed to both authors, and whether “the share of each in its success cannot be appraised,” favors the Riehlin heirs, in light of the summary judgment standard.
Aalmuhammed,
Given that the two primary Aalmu-hammed factors weigh most heavily in favor of Appellees, we hold that Riehlin was not a coauthor of the Motion Picture. Therefore, there is no renewal interest in the Motion Picture that might conceivably have vested in the Riehlin heirs under a theory of coauthorship.
B. Significance of “Publication” of the Treatment
At the time the Treatment was incorporated into the Motion Picture,
11
the
Our analysis begins with an assessment of exactly what rights Richlin did and did not own when he assigned all rights in the Treatment to Mirisch on May 24, 1962. The original copyright in the Motion Picture is governed by the 1909 Act because the Treatment and the Motion Picture were created before January 1, 1978, when the Copyright Act of 1976 (“1976 Act”) became effective. 17 U.S.C. § 304 (1976). The copyright was renewed in 1991, after the effective date of the 1976 Act. Thus, to analyze questions arising from events that occurred before January 1, 1978, such as who is the author of the Treatment, the 1909 Act applies; for events that occurred after that date, such as registration of the renewal copyright, the 1976 Act applies. See 1 Nimmer OV-7 (“In determining the corpus of law that governs a particular situation, the guiding principle should be to apply the law in effect when the infringement (or other activity), upon which suit is based, arises.”).
Unlike the 1976 Act, the 1909 Act recognized a distinction between state (or common law) and federal copyright protection.
Batjac,
Because the Treatment was not published at the time of the Assignment, Richlin’s and Edwards’s property interest in it is governed by California law at the time of transfer.
Wheaton v. Peters,
California common law copyright provided for two key mechanisms to divest the copyright owner of his copyright—publication and transfer. Once the copyright owner published his work, it lost all common law copyright protection.
13
See Carpenter,
It is undisputed that the Treatment was unpublished and not the subject of federal statutory copyright protection when Rich-lin and Edwards transferred it to Mirisch. The transfer of that state common law right neither invested the Treatment with statutory copyright protection nor divested the work of its common law copyright protection. The significance of the transfer, however, is that Mirisch became the owner of the common law copyright in the Treatment. See id. In 1963, Mirisch published the Motion Picture with notice, thus securing federal statutory protection for the Motion Picture.
Acknowledging that the Treatment was unpublished until its copyrightable elements were published by virtue of the release and distribution of the Motion Picture in 1963 as components thereof, the Richlin heirs argue, in misplaced reliance upon our decision in
Batjac,
that the 1991 renewal of the Motion Picture effected a renewal of the unpublished Treatment’s— now statutory—copyright. In
Batjac,
James Edward Grant wrote an original screenplay entitled “McLintoek!” and almost immediately assigned all rights in the unpublished screenplay to Batjac, who incorporated the screenplay into the motion picture by the same name.
Batjac,
Under
Batjac,
publication of the Motion Picture published those elements of the Treatment incorporated into the Motion Picture,
see
17 U.S.C. § 3 (1909), and thus the Motion Picture’s federal statutory copyright protection extended to those copyrightable elements of the Treatment that were published as components of the Motion Picture; however, this did not constitute publication of the Treatment “as such”—i.e., as a work standing alone. We have held that courts should generally defer to the Register of Copyright’s (“Register”) interpretation of the copyright statutes, as “ ‘[t]he Register has the authority to interpret the copyright laws and ... its interpretations are entitled to judicial deference if reasonable.’ ”
Batjac,
Publication of a portion of a work does not necessarily mean that the work as a whole has been published.
Examples:
(1) Publication of a detailed plot summary of a play does not constitute publication of the play as a whole.
(2) Publication of a movie version of an unpublished story does not constitute publication of the story as such.
Batjac,
Richlin died in 1990. Had the Treatment become the subject of statutory copyright as a separate and independent work, its renewal term would not commence until 1991. According to the Rich-lin heirs, because Richlin, like Woolrich, died before the right to renew the copyright vested, the right to renew the copyright in the Treatment reverted to them. 15 The disconnect in this theory is that, unlike the story “It Had to Be Murder,” an independent work, the Treatment was never the subject of federal copyright protection as an independent work. Because it never was invested with statutory copyright protection, there was no right to renew and, therefore, no renewal right to revert to the Richlin heirs.
There, John Cassavetes authored a screenplay, but did not secure statutory copyright in the work. Id. at 1. He transferred “the rights” to Faces Music Inc., which incorporated the screenplay into the motion picture, Husbands. The motion picture received federal statutory copyright protection in 1970. Id. at 2. In 1998, when it came time to renew the motion picture’s copyright for its second term, Cassavetes’s heirs filed two renewal copyright registrations, one for the screenplay and one for the motion picture. Id. at 1. The Copyright Office issued the renewal registration in the motion picture, but denied the application for renewal of copyright in the screenplay. Id. The Cassavetes heirs appealed to the BOA, making the identical arguments as the Richlin heirs.
The BOA upheld the Copyright Office’s rejection of the heirs’ application for a renewal copyright interest in the screenplay, reasoning:
The Copyright Office considered a motion picture to be a unified work of authorship for purposes of registration under the 1909 law. The Office’s Compendium I (1973) described a motion picture as “ordinarily ... embodfying] a large number of contributions, including those of the author of the story, author of the screenplay, director, editor, cameraman, individual producer, etc. These persons are not regarded as the ‘author’ of the film in the copyright sense. Compendium I further states that most motion pictures were works made for hire, with the production company’s [sic] being the employer in most cases. The Office’s understanding of motion picture authorship ... as consisting of contributions or parts, each of which is meant to be joined to other contributions or parts, in order to produce an integrated entity underlies this understanding.
The failure of the screenplay author ... to have reserved via registration the copyright in the unpublished version of the screenplay ..., thus rendering the screenplay’s copyright for purposes of the public registration record separate and apart from the copyright in the motion picture, means that the Office, viewing the motion picture as an integrated entity, cannot now insert into the public record a claim to renewal rights owned by a party different from the owner of record of the rights in the integrated entity, i.e., in the motion picture as a whole.
Id. at 4, 6 (citations omitted).
Even absent the principle of deference to the views of the Copyright Office, we would find the BOA’s analysis persuasive. A motion picture is a work to which many contribute; however, those contributions ultimately merge to create a unitary whole. As one district court explained, “it is impossible to cleave the story, screenplay and musical score of a motion picture film from the film itself.”
Classic Film Museum, Inc. v. Warner Bros., Inc.,
The Richlin heirs turn to
Selznick v. Turner Entertainment Co.
to argue that when the original term of copyright in the Motion Picture was renewed, the statutory copyright in the Treatment was also renewed. The entire reading audience by now will know how to resolve this contention: There was no statutory copyright in the Treatment to renew; therefore, renewal of the Motion Picture’s copyright did nothing to affect the Treatment’s copyright status. In
Selznick,
the plaintiff and defendants were undisputed co-owners of a federal statutory copyright in the classic motion picture
Gone With the Wind.
The defendants filed a renewal copyright registration in their names only, and claimed that this renewal eradicated the plaintiffs interest in the copyright.
Selznick,
Therefore, the Richlin heirs’ reliance on Selznick necessarily returns us to their flawed premise that Richlin coauthored the Motion Picture, and thereby became a co-owner of the Motion Picture’s statutory copyright. Unlike in Selznick, however, Richlin was not a coauthor of the Motion Picture. Moreover, the Richlin heirs have wholly failed to demonstrate how the Motion Picture’s incorporation of the Treatment invested in them an ownership interest in the Motion Picture’s renewal copyright term. Although the Richlin heirs are correct that, under Batjac, publication of the Motion Picture also published those copyrightable elements of the Treatment incorporated into the Motion Picture, it is a nonsequitur to conclude that the Richlin heirs thereby gained a statutory copyright in the Treatment or the Motion Picture. As MGM points out, the only way on these facts for Richlin to be a co-owner of the copyright in the Motion Picture is if he had been a coauthor. Richlin, however, did not coauthor the Motion Picture. Therefore, Selznick’s holding that a joint owner who renews a copyright acts as a constructive trustee for the other joint owners is inapposite.
In the end, the Richlin heirs ask us to consider one question: “For what reason should Richlin’s heirs be treated any differently than the heirs of any other author?” The answer is clear: Richlin failed to secure federal statutory copyright protection for the Treatment. Therefore, the Treatment as such was never invested with statutory copyright, and a right to renew the original term of statutory copyright neither vested in Richlin nor reverted to his heirs. Because Richlin neither eo-owned nor coauthored the Motion Picture,
IV. CONCLUSION
For the foregoing reasons, we affirm the district court’s decision.
AFFIRMED.
Notes
. According to expert witness Dr. Drew Cas-per of the University of Southern California’s School of Cinema-TV, a treatment is a "brief outline, in prose, describing the actions of a movie plot, indicating characters along the way with little or no dialogue; it will run no more than 25 pages, it is the last stage before beginning a screenplay proper and as such, functions as a source for a script.” The Treatment is a fourteen-page mixture of story and staging. For example, the Treatment reads: "Festival that night. Table with Princess, George, Sir Charles, Simone and the Inspector. Checking on car—facts about Le Pouf—Princess sees Secretary and excuses herself. Simone and George dance. George suggests a later rendezvous. He will find a way to get rid of her husband.”
. "Publication” is a term of art in the law of copyright. Publication before the effective date of the current Copyright Act divested an author of his common law copyright rights and injected the work into the public domain free for anyone to use. Publication in accordance with the statutory formalities of the 1909 Act, 17 U.S.C. § 10 (1909), however, both divested the owner of his common law copyright and invested him with federal statutory copyright protection. The rationale for this doctrine is rooted in the United States Constitution, which provides that ”[t]he Congress shall have power .... [t]o promote the progress of science and useful arts, by securing, for limited times to authors and inventors, the exclusive right to their respective writings and discoveries.” U.S. Const. art. I, § 8, cl. 8. In exchange for securing the exclusive right to exploit his work that federal copyright accords, the author agrees that he will enjoy this monopoly for the limited duration Congress granted in the Copyright Acts, so that the public is the ultimate beneficiary. See generally 1 M. Nimmer & D. Nimmer, Nimmer on Copyright §§ 4.01, 4.03 (2007).
. The Richlin heirs contend that the Employment Agreement was executed on June 12, 1962. The precise date of the contract's execution does not affect our holding.
. A letter dated June 28, 1962, confirmed that "the $150,000 payment for property [the Treatment] and screenplay is divided $50,000 for property and $100,000 for screenplay.”
. Although Richlin assigned to Mirisch all rights in the unpublished Treatment, an assignment of a statutory renewal copyright, assuming the Treatment became the subject of statutory copyright, would not become effective unless the author/assignor lives to the commencement of the renewal term, which is when the renewal interest vests in the author.
See Stewart v. Abend,
.A Shot in the Dark (1964); Inspector Clouseau (1968); The Return of the Pink Panther (1975); The Pink Panther Strikes Again (1976); Revenge of the Pink Panther (1978); Trail of the Pink Panther (1982); Curse of the Pink Panther (1983); Son of the Pink Panther (1993); and The Pink Panther (2006).
. Under the 1909 Act, as amended, federal copyright protection was secured "by publication thereof with the notice of copyright required by [§ 19] of this title.” 17 U.S.C. § 10 (1909). There is no dispute that the Motion Picture was released and distributed with proper notice in 1963, although it was not registered with the U.S. Copyright Office until 1964. Because "the copyright secured by [the 1909 Act] ... endure[d] for twenty-eight years from the date of first publication,” 1991 was the year the original term would expire. See id. § 24. The Renewal Registration identifies its effective date as February 13, 1991.
. The Richlin heirs' claim to the renewal copyright in the Motion Picture rests on the rule that an assignment of renewal rights by the author of a copyrighted work does not become effective unless the renewal interest vests in the then-living author.
See Abend,
. On November 25, 1992, MGM sent a check for $8,563.62 and a letter to Richlin's widow, Louise Richlin, stating "[t]his check constitutes payment in full for any rights used in or relating to[Son of Pink Panther] that are owned or controlled by Maurice Richlin or by you pursuant to the Writers Guild of America agreement or otherwise.”
Upon first inspection, this would appear to be a clue as to which parties or persons own the renewal interest in the Motion Picture. However, such monies paid are but one more lead into a dead end. In February 1965, Richlin, Edwards, and the Writers Guild of America entered into a settlement agreement with Mirisch resolving a dispute regarding A Shot in the Dark and the applicability of sequel payments. The check paid to Louise Richlin in 1992 was issued pursuant to this settlement agreement, which is a contractual matter unrelated to the question of ownership of the renewal copyright interest in the Motion Picture.
. Edwards was nominated for an Academy Award in 1982 for writing Victor/Victoria, and received an honorary Academy Award in 2003 “in recognition of his writing, directing and producing an extraordinary body of work for the screen,” such as The Pink Panther series and Breakfast at Tiffany’s.
. All parties agree, at least for purposes of summary judgment and appeal, that the Treatment was incorporated into the Motion Picture. Those copyrightable elements of the Treatment that were not incorporated into the Motion Picture retained their common law copyright protection because they were not published, and received statutory copyright protection with the enactment of the 1976 Act.
See
17 U.S.C. § 303(a) (1976); 3 Nimmer § 9.09[A]. The questions of whether any such copyrightable elements that were not incorpo
. According to the Richlin heirs, because Edwards lived to the renewal term, MGM retained the right to renew the supposed statutory copyright in the Treatment, even though Richlin’s interest in the Treatment had reverted to his heirs.
. If the owner of a common law copyright published the work without complying with federal statutory requirements, it would enter the public domain.
Abend,
. Although the copyright in the Motion Picture “protect[ed] all the copyrightable component parts of the work,” 17 U.S.C. § 3 (1909), that is not the same as securing a copyright in those component parts. Richlin and Edwards
. Under this theory, during the supposed first term of copyright, the Richlin heirs would have had no interest because Richlin was free to assign, and did assign, all rights to Mirisch.
